Article Information
History
- March 23, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ernst Mayerhofer, MD1,2,3,4,7,
- Rainer Malik, PhD5,
- Livia Parodi, PhD1,2,3,4,
- Stephen Burgess, PhD6,
- Andreas Harloff, MD7,
- Martin Dichgans, MD5,8,9,
- Jonathan Rosand, MD, MSc1,2,3,4,
- Christopher D Anderson, MD, MMSc1,2,3,4,10,† and
- Marios K Georgakis, MD, PhD1,2,3,4,5,†,*
- 1Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
- 2Program in Medical and Population Genetics, Broad Institute of Harvard and the Massachusetts Institute of Technology, Boston, MA, USA
- 3Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA
- 4Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- 5Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany
- 6University of Cambridge, MRC Biostatistics Unit, Cambridge United Kingdom
- 7Department of Neurology and Neurophysiology, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
- 8German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany
- 9Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- 10Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA
- ↵*Correspondence to:
Marios K. Georgakis, MD, PhD, Center for Genomic Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, Tel: (617) 726-5942, e-mail: mgeorgakis{at}mgh.harvard.edu; marios.georgakis{at}med.uni-muenchen.de
↵† These authors contributed equally to this work.
Posted March 23, 2022.
Genetically predicted on-statin LDL response is associated with higher intracerebral hemorrhage risk
